None

Amgen and Kleiner Perkins Caufield & Byers partner to create new spin-out biotech company

Amgen and Kleiner Perkins Caufield & Byers announced the formation of Atara Biotherapeutics, a new drug development company with a focus on innovative therapies for patients with chronic diseases...

Brook Byers of Kleiner Perkins on Sticking With Healthcare

Kleiner Perkins Caufield & Byers is one of the kingpins of venture capital, best known as the firm that got in on the ground floor at Google, Amazon, Genentech and plenty of other industry-definin...

Asset supplier Amgen and investor Kleiner Perkins tight-lipped on Atara startup

If loose lips sink ships then Amgen and its venture capital partner Kleiner Perkins Caufield & Byers (KPCB) have nothing to worry about when it comes to their new startup Atara Biotherapeutics, which...

Amgen, Kleiner Perkins launch Atara

Amgen Inc. (NASDAQ:AMGN) and VC firm Kleiner Perkins Caufield & Byers launched newco Atara Biotherapeutics Inc. to develop six assets licensed from Amgen. The companies said the assets are in various...

Kleiner Perkins’ Waste-to-Energy Play, Harvest Power, Bets $150M on Turning Compost Into Natural Gas

The team at Kleiner Perkins Caufield & Byers gets inundated with pitches from entrepreneurs who dream of winning support for their own big ideas. But once in a while, the big VC firm turns the tab...

Kleiner Perkins’ Organic Waste-to-Energy Play, Harvest Power, Bets $150M on Turning Compost Into Natural Gas

The team at Kleiner Perkins Caufield & Byers gets inundated with pitches from entrepreneurs who dream of winning support for their own big ideas. But once in a while, the big VC firm turns the tab...

Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News

We had a grab bag of life sciences-related coverage this week, with a big device company acquisition, some wild ideas for global health, and a whole lot of focus on biofuels. —Kleiner Perkins Ca...

Amgen launches new drug discovery company

Amgen teamed up with Kleiner Perkins Caufield & Byers to establish Atara Biotherapeutics.  -More- 

Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98

An inactivated cell-culture vaccine against yellow fever.

Yellow fever is a lethal viral hemorrhagic fever occurring in Africa and South America. A highly effective live vaccine (17D) is widely used for travelers to and residents of areas in which yellow fev...

Capricious cre: the devil is in the details.

Brown adipose tissue: mechanisms and potential therapeutic targets.

Outcomes of the Laparoscopic Sleeve Gastrectomy in the Medicare Population.